- Home
- FUSB vs CLSD Comparison
FUSB vs CLSD Comparison
Compare FUSB & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUSB
- CLSD
- Stock Information
- Founded
- FUSB 1952
- CLSD 2011
- Country
- FUSB United States
- CLSD United States
- Employees
- FUSB N/A
- CLSD N/A
- Industry
- FUSB Major Banks
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- FUSB Finance
- CLSD Health Care
- Exchange
- FUSB Nasdaq
- CLSD Nasdaq
- Market Cap
- FUSB 73.3M
- CLSD 70.5M
- IPO Year
- FUSB N/A
- CLSD 2016
- Fundamental
- Price
- FUSB $12.50
- CLSD $1.01
- Analyst Decision
- FUSB
- CLSD Strong Buy
- Analyst Count
- FUSB 0
- CLSD 6
- Target Price
- FUSB N/A
- CLSD $5.33
- AVG Volume (30 Days)
- FUSB 1.8K
- CLSD 144.0K
- Earning Date
- FUSB 01-27-2025
- CLSD 03-11-2025
- Dividend Yield
- FUSB 2.27%
- CLSD N/A
- EPS Growth
- FUSB 0.00
- CLSD N/A
- EPS
- FUSB 1.33
- CLSD N/A
- Revenue
- FUSB $39,110,000.00
- CLSD $7,703,000.00
- Revenue This Year
- FUSB N/A
- CLSD N/A
- Revenue Next Year
- FUSB N/A
- CLSD $91.87
- P/E Ratio
- FUSB $9.29
- CLSD N/A
- Revenue Growth
- FUSB N/A
- CLSD 248.39
- 52 Week Low
- FUSB $8.66
- CLSD $0.80
- 52 Week High
- FUSB $14.30
- CLSD $2.12
- Technical
- Relative Strength Index (RSI)
- FUSB 48.06
- CLSD 47.63
- Support Level
- FUSB $12.25
- CLSD $0.90
- Resistance Level
- FUSB $12.80
- CLSD $0.96
- Average True Range (ATR)
- FUSB 0.29
- CLSD 0.05
- MACD
- FUSB -0.01
- CLSD 0.00
- Stochastic Oscillator
- FUSB 33.71
- CLSD 50.63
About FUSB First US Bancshares Inc.
First US Bancshares Inc is a bank holding company. The Bank conducts general commercial banking business and offers banking services such as demand, savings, individual retirement account and time deposits, personal and commercial loans, safe deposit box services and remote deposit capture. The Bank provides a range of commercial banking services to small and medium-sized businesses, property managers, business executives, professionals and other individuals.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.